GoodRx Holdings (GDRX) Total Liabilities (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Total Liabilities data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 118.32% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $1.4 billion (up 118.32% YoY), and the FY2025 full-year result was $787.8 million, up 18.75% from the prior year.
• Total Liabilities advanced to $1.4 billion in Q1 2026, from $787.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.4 billion in Q1 2026 to a low of $640.9 million in Q1 2025.
• A 5-year average of $794.6 million and a median of $784.0 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities slipped 22.11% in 2025 and soared 118.32% in 2026, its largest moves.
• Tracing GDRX's Total Liabilities over 5 years: stood at $789.8 million in 2022, then grew by 4.69% to $826.8 million in 2023, then decreased by 19.77% to $663.4 million in 2024, then climbed by 18.75% to $787.8 million in 2025, then surged by 77.62% to $1.4 billion in 2026.
• Business Quant data shows GDRX's Total Liabilities at $1.4 billion in Q1 2026, $787.8 million in Q4 2025, and $724.8 million in Q3 2025.